Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage [R9S4bdD_jQh]

Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage [R9S4bdD_jQh]

| 1h 28m 28s | Video has closed captioning.

Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it means for Eli Lilly's future growth. #oprahs gummies weight loss #lean start keto pills reviews #adken acv keto gummies

Aired: December 27, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage [R9S4bdD_jQh] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage [R9S4bdD_jQh] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage [R9S4bdD_jQh] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now